Interferon-γ affects leukemia cell apoptosis through regulating Fas/FasL signaling pathway

Area of Science:

• Hematology
• Molecular Biology
• Cancer Research

Background:

• Leukemia pathogenesis involves dysregulated hematopoietic cell proliferation and apoptosis.
• The Fas/FasL signaling pathway is critical for inducing programmed cell death (apoptosis).
• Understanding factors that modulate these processes is key to developing leukemia therapies.

Purpose of the Study:

• To investigate the effect of interferon gamma (IFN-γ) on chronic myelogenous leukemia (CML) cell proliferation and apoptosis.
• To elucidate the interaction between IFN-γ and the Fas/FasL signaling pathway in K562 CML cells.

Main Methods:

• K562 CML cells were treated with varying concentrations of IFN-γ (10, 100, 1000 U/ml) for different durations (12, 24, 48 hours).
• Cell proliferation was assessed using MTT assays.
• Apoptosis was quantified via TUNEL assays.
• Fas and FasL protein expression levels were determined using Western blot analysis.

Main Results:

• IFN-γ demonstrated a dose- and time-dependent inhibition of K562 cell proliferation, with the strongest effect observed at 1000 U/ml for 48 hours (p < 0.05).
• IFN-γ significantly enhanced K562 cell apoptosis in a concentration- and time-dependent manner (p < 0.05).
• Treatment with IFN-γ led to a significant upregulation of both Fas and FasL protein expression (p < 0.05).

Conclusions:

• Interferon gamma exerts an inhibitory effect on leukemia K562 cell proliferation.
• IFN-γ promotes apoptosis in K562 cells.
• These effects are mediated through the facilitation of Fas and FasL protein expression, highlighting the role of the Fas/FasL pathway.